CRT 2023
Endovascular Hot Topics
William A. Gray, MD, FSCAI
System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
Main Line Health
Wynnewood, Pennsylvania, United States
Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)
Thomas Zeller, MD
Director Department Angiology
Universitäts-Herzzentrum Freiburg - Bad Krozingen
Bad Krozingen, Baden-Wurttemberg, Germany
Disclosure(s): Abbott Vascular, BIBA Medical, Biotronik, Boston Scientific Corp., Cook Medical, Efemoral, Gore & Associates, Medtronic, Philips-Spectranetics, Shockwave, Veryan: Honoraria (Ongoing); Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, B. Braun; CSI, Boston Scientific, University of Jena, Pluristem, PQ Bypass, Surmodics, Reflow: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant/Research Support (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific Corp., CSI, Gore & Associates, Medtronic, Veryan, Philips-Intact Vascular, Shockwave, Bayer, Vesper Medical, VentureMed, ANT: Consultant (Ongoing), Consultant/Advisory Board (Ongoing)
James P. Zidar, MD, FSCAI
Clinical Professor of Medicine
University of North Carolina/Rex Healthcare
Raleigh, North Carolina, United States
Disclosure(s): cordis: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing), Consulting fees or other remuneration (Ongoing)